Loading stock data…
$1.26-0.02 (-1.94%)
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
Myomo, Inc. in the Healthcare sector is trading at $1.26 with a market capitalization of $50M. Wall Street consensus targets $4.64 (5 analysts), implying a +266.8% move over the next 12 months. The stock is currently 33% below its 52-week high of $1.89, remaining 19.3% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 20 is oversold, raising the odds of a near-term bounce. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.70M↑ | $10.11M↓ | $11.35M↑ | $10.09M↑ | $9.65M |
| Gross Profit | $8.44M↑ | $6.90M↓ | $7.78M↑ | $6.44M↑ | $6.05M |
| Operating Income | -$2.25M↑ | -$3.16M↓ | -$2.77M↑ | -$3.52M↑ | -$4.59M |
| Net Income | -$4.02M↓ | -$3.01M↑ | -$3.81M↓ | -$3.66M↑ | -$4.63M |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled up...